Unilever Teams up with H.E.A.R.T. UK to Provide Heart Healthy Checks to More than 100,000 People across the UK HAYWARD, Calif., and LONDON, May 4 /PRNewswire-FirstCall/ -- Cholestech Corporation (NASDAQ:CTEC) announced that Flora pro.activ, the UK's leading cholesterol lowering brand, has selected the Cholestech LDX(R) System, a leading cholesterol monitoring tool, as part of the "Test the Nation" program. This is the second national heart health initiative that has used the Cholestech LDX System as the Swiss Heart Foundation recently submitted results of its national screening program to the Swiss Health Ministry. (Photo: http://www.newscom.com/cgi-bin/prnh/20060504/NYTH042 ) The "Test the Nation" program is being run by Flora pro.activ, in association with H.E.A.R.T. UK, the Hyperlipidaemia Education and Research Trust. The program aims to provide the necessary information that will encourage people to find out what shape their heart is in and take responsibility for their heart health. The campaign kicked off at the start of April, 2006 and takes place at city centres, supermarkets and major events including the Flora London Marathon on April 23. Over the next four months, Unilever will be offering free heart health checks with fully qualified nurses and expert advice on diet and lifestyle. In addition to free blood pressure and cholesterol testing with a qualified nurse, everyone tested will receive a Complete Guide to Heart Health. The cholesterol screening will be conducted using the Cholestech LDX(R) System, which generates comprehensive lab-accurate results in minutes. Using a simple finger-stick, the LDX System can measure cholesterol, glucose and liver enzymes, and now, high sensitivity C-reactive protein (hs-CRP). This enhances the ability to quickly identify patients with risk factors for heart disease, enabling physicians to focus on getting patients on the right treatment sooner and making sure they stay on the right therapeutic mix. Commenting on the campaign, Michael Livingston, Director, H�E�A�R�T UK said, "Raising awareness and educating the public about blood pressure and cholesterol can have a major impact on the nation's heart health. H.E.A.R.T UK believes that Flora pro.activ's campaign will show the public how making simple changes to their diet and lifestyle can have beneficial effects, thus encouraging people to take important and significant responsibility for their own heart health." The Cholestech LDX System, which carries the CE Mark for marketing of medical devices in the European Union, has been certified by the United States Cholesterol Reference Method Laboratory Network (CRMLN), which validates that the system meets the gold standard for accuracy and reproducibility developed by the Centers for Disease Control and Prevention (CDC) for the measurement of total cholesterol and HDL cholesterol consistent with National Cholesterol Education Program (NCEP) analytical goals. The NCEP recommends that everyone over the age of 20, or more than 200 million Americans, should be screened for cholesterol. "Cholestech is proud to support the 'Test the Nation' program and we commend Flora pro.activ and H.E.A.R.T UK for their dedication to giving consumers the education and tools they need to take control of their own heart health, including accurate diagnostic results available in minutes for immediate counseling and action," said Warren E. Pinckert II, president and CEO of Cholestech. The "Test the Nation" Program is being implemented and supported locally by Point of Care Services Limited, Cholestech's partner in the United Kingdom. About Flora pro.activ Flora pro.activ is the leading heart health brand in the UK and has 2 ranges of products. The first contains plant sterols which are clinically proven to dramatically lower bad (LDL) cholesterol by 10-15% in 3 weeks as part of a healthy diet. Consumers can chose from spread, milk drink, yogurt or yogurt drinks to help lower their cholesterol. The second range is a yogurt drink that contains AmealPeptides(TM) a type of naturally occurring dairy peptide. Scientific studies show that they help control blood pressure to maintain a healthy heart. For more information on Flora pro.activ or the Test The Nation road show visit http://www.floraproactiv.co.uk/ About Cholestech Cholestech is committed to enabling people to lead longer, healthier and more active lives. Cholestech provides easy to use, accessible diagnostic tools and information to health care practitioners in over 35 countries around the world. Cholestech offers efficient and economic diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, high sensitivity C-reactive protein and liver function at the point of care. Health care providers can use the CLIA-waived Cholestech LDX(R) and GDX(TM) Systems and the hs-CRP test, which is cleared by the FDA for use in moderate complexity labs, to initiate and monitor the progress of patient therapy. By providing effective disease management solutions, Cholestech's goal is to be a leading provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes. Cholestech LDX(R) is a registered trademark and Cholestech GDX(TM) is a trademark of Cholestech Corporation. All other trademarks mentioned in this document are the property of their respective owners. For more information about Cholestech and its products visit us on the web at http://www.cholestech.com/. http://www.newscom.com/cgi-bin/prnh/20060504/NYTH042 http://photoarchive.ap.org/ DATASOURCE: Cholestech Corporation CONTACT: Warren E. Pinckert II, President and Chief Executive Officer of Cholestech Corporation, +1-510-732-7200, ; or Sarah Thomas for Flora pro.activ, +020-7331-5447, Web site: http://www.florahearts.co.uk/ http://www.cholestech.com/

Copyright

Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Global X CleanTech ETF Charts.
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Global X CleanTech ETF Charts.